Mass Tort

Uloric

How We Can Help

Get More Qualified Leads Using Facebook

The U.S. Food and Drug Administration approved Uloric medication in 2009, and the drug quickly became a popular first choice for treating gout. In 2018, a clinical trial funded by Takeda found an increased risk of heart-related death, as well as death from all causes, in people who took Uloric.

The FDA added a black box warning, the agency’s most serious warning, to Uloric’s label in February 2019, but it left the drug on the market. People who took the medication and suffered cardiovascular events and survivors of people who died have begun filing Uloric lawsuits.

At Law Scout, we build a customizable Facebook campaign to reach Uloric users for your firm who are thoroughly vetted based on YOUR criteria. We can meet your firm’s lead volume needs without sacrificing quality.

Get Started
How Mass Tort can grow your firm
Lawyers in the United States spend more than $1 billion on advertising and marketing services. And of that $1 billion, mass tort advertising consumes about $850 million.
Mass Tort cases can include dangerous drugs, defective products, and abuse.
q
More than 30 dangerous drugs have been approved and later taken off the market because of serious health risks since the 1970’s

A Smarter Way to Find Future Clients

It’s easy to get started, simple to use, and we’re with you each step of the way.

Talk to Us